Aswathy Shailaja

Dr. Aswathy Shailaja

Duke University School of Medicine, Durham, North Carolina, USA
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 August 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Mina ZareMina Zare
Mina Zare
RPRakesh Pemmada
Rakesh Pemmada
MMMaya Madhavan
Maya Madhavan
ASAswathy Shailaja
Aswathy Shailaja
Seeram RamakrishnaSeeram Ramakrishna
Seeram Ramakrishna
Vinoy ThomasVinoy Thomas
Vinoy Thomas
Globally, cancer is amongst the most deadly diseases due to the low efficiency of the conventional and obsolete chemotherapeutic methodologies and their many downsides. The poor aqueous solubility of most anticancer medications and their low biocompatibility make them ineligible candidates for the design of delivery systems. A significant drawback associated with chemotherapy is that there are no advanced solutions to multidrug resistance, which poses a major obstacle in cancer management. Since RNA interference (RNAi) can repress the expression of genes, it is viewed as a novel tool for advanced drug delivery. this is being explored as a promising drug targeting strategy for the treatment of multiple diseases, including cancer. However, there are many obstructions that hinder the clinical uses of siRNA drugs due to their low permeation into cells, off-target impacts, and possible unwanted immune responses under physiological circumstances. Thus, in this article, we review the design measures for siRNA conveyance frameworks and potential siRNA and miRNA drug delivery systems for malignant growth treatment, including the use of liposomes, dendrimers, and micelle-based nanovectors and functional polymer–drug delivery systems. This article sums up the advancements and challenges in the use of nanocarriers for siRNA delivery and remarkably centers around the most critical modification strategies for nanocarriers to build multifunctional siRNA and miRNA delivery vectors. In short, we hope this review will throw light on the dark areas of RNA interference, which will further open novel research arenas in the development of RNAi drugs for cancer.

28 October 2022 in Biofilm
Verified
Journal Article
Open access
ASAswathy Shailaja
Aswathy Shailaja
TBTerri F. Bruce
Terri F. Bruce
PGPatrick Gerard
Patrick Gerard
RPRhonda R. Powell
Rhonda R. Powell
CPCharles A. Pettigrew
Charles A. Pettigrew
JKJulia L. Kerrigan
Julia L. Kerrigan
Filamentous fungi are ubiquitous and frequent components of biofilms. A means to visualize them and quantify their viability is essential for understanding their development and disruption. However, quantifying filamentous fungal biofilms poses challenges because, unlike yeasts and bacteria, they are not composed of discrete cells of similar size. This research focused on filamentous fungal biofilms that are representative of those in the built environment. The objective of this study was to develop a rapid method to examine biofilm structure and quantify live (metabolically active/ membrane undamaged) and dead (inactive/ membrane damaged) cells in Aspergillus niger biofilms utilizing a fluorescent probe staining method and confocal laser scanning microscopy (CLSM). For this, we compared two commercially available probe staining kits that have been developed for bacterial and yeast systems. One method utilized the classic cell stain FUN 1 that exhibits orange-red fluorescent intravacuolar structures in metabolically active cells, while dead cells are fluoresced green. The second method utilized a combination of SYTO9 and propidium iodide (PI), and stains cells based on their membrane morphology. SYTO9 is a green fluorescent stain with the capacity to penetrate the living cell walls, and PI is a red fluorescent stain that can only penetrate dead or dying cells with damaged cell membranes. Following staining, the biofilms were imaged using CLSM and biofilm volumes and thickness were quantified using COMSTAT, a computer program that measures biofilm accumulation from digital image stacks. The results were compared to independent measurements of live-dead cell density, as well as a classic cell viability assay-XTT. The data showed that the combination of SYTO9 and PI is optimal for staining filamentous fungal biofilms.

26 March 2024 in Cell Stem Cell
Verified
Journal Article
Closed access
AEAdrian A. Epstein
Adrian A. Epstein
SJSara N. Janos
Sara N. Janos
LMLuca Menozzi
Luca Menozzi
KPKelly Pegram
Kelly Pegram
VJVaibhav Jain
Vaibhav Jain
EBEric J. Benner
Eric J. Benner

15 July 2022 in Pathogens
Verified
Journal Article
Open access
PDF file
DRDhanya C R
Dhanya C R
ASAswathy Shailaja
Aswathy Shailaja
AMAarcha Shanmugha Mary
Aarcha Shanmugha Mary
SKSumodan P K
Sumodan P K
ASAmbili Savithri
Ambili Savithri
MMMaya Madhavan
Maya Madhavan
Pathogenic viruses with an RNA genome represent a challenge for global human health since they have the tremendous potential to develop into devastating pandemics/epidemics. The management of the recent COVID-19 pandemic was possible to a certain extent only because of the strong foundations laid by the research on previous viral outbreaks, especially Ebola Virus Disease (EVD). A clear understanding of the mechanisms of the host immune response generated upon viral infections is a prime requisite for the development of new therapeutic strategies. Hence, we present here a comparative study of alterations in immune response upon SARS-CoV-2 and Ebola virus infections that illustrate many common features. Vaccination and pregnancy are two important aspects that need to be studied from an immunological perspective. So, we summarize the outcomes and immune responses in vaccinated and pregnant individuals in the context of COVID-19 and EVD. Considering the significance of immunomodulatory approaches in combating both these diseases, we have also presented the state of the art of such therapeutics and prophylactics. Currently, several vaccines against these viruses have been approved or are under clinical trials in various parts of the world. Therefore, we also recapitulate the latest developments in these which would inspire researchers to look for possibilities of developing vaccines against many other RNA viruses. We hope that the similar aspects in COVID-19 and EVD open up new avenues for the development of pan-viral therapies.


12 May 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
ASAswathy Shailaja
Aswathy Shailaja
TBTerri F. Bruce
Terri F. Bruce
PGPatrick Gerard
Patrick Gerard
JKJulia L. Kerrigan
Julia L. Kerrigan
Aspergillus niger is a filamentous fungus that adheres to different substrate surfaces and form biofilms consisting of dense hyphal networks embedded in a self-produced gelatinous matrix composed of extracellular polymeric substance (EPS). The EPS mainly contains exopolysaccharides. The objective of this study was to visualize and assess the different exopolysaccharides structure in this extracellular polymeric substance using a combination of two different fluorescent-labeled lectin probes, Erythrina cristagalli (ECA) and Canavalia ensiformis (Con A). Each lectin is a unique protein that binds to specific a carbohydrate moiety and is classified based on these terminal sugars to which they are binding. Exopolysaccharides are imaged according to their distinct fluorescence color with the help of confocal laser scanning microscopy (CLSM). The biomass, average thickness, and roughness of biofilms were calculated from the Z-stack images using the computer program COMSTAT. A statistically significant difference was observed in the biomass (μm 3 /μm 2 ), average thickness (μm), and roughness of the biofilm treated with the two different lectin probes indicating the presence of a higher amount of galactose and β-1,4 N-acetylgalactosamine (β4GalNAc) when compared to the mannose and glucose moieties in the EPS of A.niger biofilm. The combination of two lectin-fluorescent probe method staining should help better characterization of A. niger biofilms in terms of their heterogeneity with regards to the EPS production.